DOI QR코드

DOI QR Code

소아청소년 틱장애 환자의 B림프구에서 D8/17의 발현

D8/17 Expression on B Lymphocytes of Children and Adolescents with Tic Disorder

  • 오영근 (전북대학교 의학전문대학원 정신과학교실) ;
  • 박태원 (전북대학교 의학전문대학원 정신과학교실) ;
  • 정용우 (고려대학교 약학대학 약학과) ;
  • 정상근 (전북대학교 의학전문대학원 정신과학교실) ;
  • 정영철 (전북대학교 의학전문대학원 정신과학교실) ;
  • 양종철 (전북대학교 의학전문대학원 정신과학교실)
  • Oh, Young-Gun (Department of Psychiatry, Chonbuk National University Medical School and Institute for Medical Sciences) ;
  • Park, Tae-Won (Department of Psychiatry, Chonbuk National University Medical School and Institute for Medical Sciences) ;
  • Jung, Yong Woo (Department of Pharmacy, Korea University) ;
  • Chung, Sang-Keun (Department of Psychiatry, Chonbuk National University Medical School and Institute for Medical Sciences) ;
  • Chung, Young-Chul (Department of Psychiatry, Chonbuk National University Medical School and Institute for Medical Sciences) ;
  • Yang, Jong-Chul (Department of Psychiatry, Chonbuk National University Medical School and Institute for Medical Sciences)
  • 투고 : 2013.07.24
  • 심사 : 2013.09.17
  • 발행 : 2013.09.30

초록

Objectives : It has been reported that higher percentage of B cells react with monoclonal D8/17 antibody in patients with rheumatic fever, childhood onset obsessive-compulsive disorder, Tourette's disorder, or prepubertal anorexia nervosa. The purpose of this study is to replicate the previous studies in a Korean young population with tic disorder and to identify any relationship between D8/17 and clinical symptoms. Methods : The binding of D8/17 to B cells was determined in patients with tic disorder (N=21) and healthy controls (N=9) by Fluorescence-Activated Cell Sorter analysis. Results : In the sample examined by this study, the average percentage of B cells expressing D8/17 in tic disorder was 2.05%; healthy controls was 3.15%. No statistically significant differences were found in the mean percentages of D8/17 between the two groups. Conclusion : The expression of D8/17 in B cells was very low in this study. No subjects with tic disorder or healthy controls was above 12% in D8/17 positive proportion. Further studies, including higher number of patients and control group members, should be performed.

키워드

참고문헌

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
  2. Leckman JF. Tourette's syndrome. Lancet 2002;360:1577-1586. https://doi.org/10.1016/S0140-6736(02)11526-1
  3. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271.
  4. Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 2001;138:71-75. https://doi.org/10.1067/mpd.2001.110325
  5. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF. Immunopathogenic mechanisms in tourette syndrome: a critical review. Mov Disord 2009;24:1267-1279. https://doi.org/10.1002/mds.22504
  6. Khanna AK, Buskirk DR, Williams RC Jr, Gibofsky A, Crow MK, Menon A, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989;83:1710-1716. https://doi.org/10.1172/JCI114071
  7. Zabriskie JB, Lavenchy D, Williams RC Jr, Fu SM, Yeadon CA, Fotino M, et al. Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum 1985;28:1047- 1051. https://doi.org/10.1002/art.1780280912
  8. Koren W, Koldanov R, Postnov I, Morozova E, Zolkina I, Enina L, et al. Red cell Na+/H+ exchange and B cell alloantigen 883 (D8/17) in patients with acute rheumatic fever and inactive rheumatic heart disease. Scand J Rheumatol 1996;25:87-91. https://doi.org/10.3109/03009749609069213
  9. Giedd JN, Rapoport JL, Leonard HL, Richter D, Swedo SE. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J Am Acad Child Adolesc Psychiatry 1996;35:913-915. https://doi.org/10.1097/00004583-199607000-00017
  10. Lee YS, Joung YS. A Prelimimary study of B lymphocyte antigen D8/17 in Tourette syndrome who suggested PANDAS. Korean J Child & Adol Psychiatr 2006;17:27-31.
  11. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36:980-988. https://doi.org/10.1097/00004583-199707000-00021
  12. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (KSADS- PL-K). Yonsei Med J 2004;45:81-89. https://doi.org/10.3349/ymj.2004.45.1.81
  13. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician- rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566-573. https://doi.org/10.1097/00004583-198907000-00015
  14. Chung SJ, Lee JS, Yoo Tl, Koo YJ, Jeon SI, Kim BS, et al. Development of Korean Form of Yale Global Tic Severity Scale: a validity and reliability study. J Korean Neuropsychiat Assoc 1998;37:942- 951.
  15. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997;36:844-852. https://doi.org/10.1097/00004583-199706000-00023
  16. Murphy TK, Goodman WK, Fudge MW, Williams RC Jr, Ayoub EM, Dalal M, et al. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette’s syndrome? Am J Psychiatry 1997;154:402-407. https://doi.org/10.1176/ajp.154.3.402
  17. Chapman F, Visvanathan K, Carreño-Manjarrez R, Zabriskie JB. A flow cytometric assay for D8/17 B cell marker in patients with Tourette’s syndrome and obsessive compulsive disorder. J Immunol Methods 1998;219:181-186. https://doi.org/10.1016/S0022-1759(98)00141-0
  18. Hoekstra PJ, Bijzet J, Limburg PC, Steenhuis MP, Troost PW, Oosterhoff MD, et al. Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients. Am J Psychiatry 2001;158:605-610. https://doi.org/10.1176/appi.ajp.158.4.605
  19. Morer A, Viñas O, Lázaro L, Calvo R, Andrés S, Bosch J, et al. Subtyping obsessive-compulsive disorder: clinical and immunological findings in child and adult onset. J Psychiatr Res 2006;40:207-213. https://doi.org/10.1016/j.jpsychires.2005.04.003
  20. Eisen JL, Leonard HL, Swedo SE, Price LH, Zabriskie JB, Chiang SY, et al. The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder. Psychiatry Res 2001;104:221-225. https://doi.org/10.1016/S0165-1781(01)00323-7
  21. Hollander E, DelGiudice-Asch G, Simon L, Schmeidler J, Cartwright C, DeCaria CM, et al. B lymphocyte antigen D8/17 and repetitive behaviors in autism. Am J Psychiatry 1999;156:317-320.
  22. Walker KG, Cooper M, McCabe K, Hughes J, Mathiassen W, Lawrenson J, et al. Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa. Cardiol Young 2011;21:328-333. https://doi.org/10.1017/S1047951111000035
  23. Morer A, Vinas O, Lazaro L, Bosch J, Toro J, Castro J. D8/17 monoclonal antibody: an unclear neuropsychiatric marker. Behav Neurol 2005;16:1-8. https://doi.org/10.1155/2005/795343
  24. Weisz JL, McMahon WM, Moore JC, Augustine NH, Bohnsack JF, Bale JF, et al. D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette’s disorder. Clin Diagn Lab Immunol 2004;11:330-336.